There were 2,052 press releases posted in the last 24 hours and 428,765 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Amphivena Therapeutics Announces Acceptance of Investigational New Drug (IND) Application for AMV564 and Planned Phase 1 Trial Initiation

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image